Gene · 8038
Papers1,979
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,979
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Molecular Analyses of Notch Pathway-Related Genes to Predict Prognosis and Immunotherapy Response in Patients with Gastric Cancer. | J Oncol | 2023 | 36733672 | PubTator, text mining | PubMed |
| ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway. | J Transl Med | 2023 | 36717944 | PubTator, text mining | PubMed |
| Differential chondrogenic differentiation between iPSC derived from healthy and OA cartilage is associated with changes in epigenetic regulation and metabolic transcriptomic signatures. | Elife | 2023 | 36715686 | PubTator, text mining | PubMed |
| The Integrative Studies on the Functional A-to-I RNA Editing Events in Human Cancers. | Genomics Proteomics Bioinformatics | 2023 | 36708807 | PubTator, text mining | PubMed |
| Validation of a multiple marker test for early pregnancy outcome prediction. | J Assist Reprod Genet | 2023 | 36708430 | PubTator, text mining | PubMed |
| 5-mRNA-based prognostic signature of survival in lung adenocarcinoma. | World J Clin Oncol | 2023 | 36699627 | PubTator, text mining | PubMed |
| Role of the extracellular matrix in COVID-19. | World J Clin Cases | 2023 | 36687194 | PubTator, text mining | PubMed |
| Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. | J Pers Med | 2023 | 36675796 | PubTator, text mining | PubMed |
| Altered host protease determinants for SARS-CoV-2 Omicron. | Sci Adv | 2023 | 36662861 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps and pulmonary fibrosis: an update. | J Inflamm (Lond) | 2023 | 36658568 | PubTator, text mining | PubMed |
| SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma. | iScience | 2023 | 36590170 | PubTator, text mining | PubMed |
| The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review. | Oncogene | 2023 | 36572816 | PubTator, text mining | PubMed |
| ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer. | Oncoimmunology | 2023 | 36545255 | PubTator, text mining | PubMed |
| ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer. | Clin Transl Oncol | 2023 | 36512304 | PubTator, text mining | PubMed |
| Biology, vulnerabilities and clinical applications of circulating tumour cells. | Nat Rev Cancer | 2023 | 36494603 | PubTator, text mining | PubMed |
| Gastric cancer detection by non-blood-based liquid biopsies: A systematic review looking into the last decade of research. | United European Gastroenterol J | 2023 | 36461757 | PubTator, text mining | PubMed |
| Serum ADAM metallopeptidase domain 12 as a promising diagnostic biomarker for breast and liver cancer. | Clin Transl Oncol | 2023 | 36183312 | PubTator, text mining | PubMed |
| Large registry-based analysis of genetic predisposition to tuberculosis identifies genetic risk factors at HLA. | Hum Mol Genet | 2023 | 36018815 | PubTator, text mining | PubMed |
| Surgical intervention after medical treatment for early pregnancy loss according to gestational size. | Int J Gynaecol Obstet | 2023 | 35899733 | PubTator, text mining | PubMed |
| Tumor-suppressor p53 specifically binds to miR-29c-3p and reduces ADAM12 expression in hepatocellular carcinoma. | Dig Liver Dis | 2023 | 35853821 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8038/papers?page=14